A recent study provided real-world data on the clinical benefits of a...
Musculoskeletal pain is more common in type-2 diabetes mellitus (T2DM) patients rather than in general population. A first-of-its-kind study...
19 Jul, 2019
A recent study advised on estimating the renal threshold for glucose reabsorption before initiating sodium glucose co-transporter-2 (SGLT2)...
16 Jul, 2019
As compared to healthy people, diabetes patients suffering with diabetic peripheral neuropathy (DPN) place their feet less accurately whilst walking...
12 Jul, 2019
Increasing dietary intake of polyunsaturated fatty acids (PUFAs), especially linoleic acid and marine n-3 PUFAs, to substitute saturated fatty acids...
According to the findings of the CREDENCE trial, canagliflozin rendered protection against renal and cardiovascular outcomes in type-2 diabetes...
Findings of the study showed that SGLT2 inhibitors effectively reduce the risk of MACE, renal outcomes, and hospitalizations for HF in T2DM patients...
This large-scale study reaffirms albuminuria to be an independent marker of subsequent all-cause mortality and cardiovascular events in insulin-...
An Indian study demonstrates persistent reduction in risk of T2DM even 3 years after withdrawal of active SMS-based lifestyle intervention.
Diabetic retinopathy (DR) is the most common and most serious of the ocular complications of diabetes mellitus. This patient education leaflet on DR...
Fasting & feasting during Ramadan in diabetes patients is associated with altered glucose level which may lead to low or high blood sugar level....
Diabetes implies high blood sugar levels in blood. Find out more about the cause, risk factors and complications associated with this disease.
The ancient science of yoga provides various health benefits to an individual. Know more about the ‘asanas’ that are beneficial for diabetes patients...
The presence of depression in patients with diabetes mellitus is of vast importance, as it is usually associated with poor disease control, adverse...
Brief information on the treatment strategy and selection of oral antihyperglycemic agents in type 2 diabetes is summarised in this document.
Most relevant information on management of dyslipidemia, a common comorbidity observed in diabetes patients, has been summarised in this document.
Hypertension elevates the risk of micro-and macro-vascular complications in diabetes. Here is a summary on the BP treatment goals in diabetes...
Fasting & feasting during Ramadan in diabetes patients is associated with increased risk of complications such as hypoglycemia, hyperglycemia,...
This slide set summarizes the key 2014 clinical practice recommendations of the American Diabetes Association (ADA) on the screening, diagnosis and...
Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...
Hypertension affects 20%-60% of diabetics. It substantially increases the risk of macrovascular and microvascular complications in diabetes. This...